(Q34742116)

4 August 2017

1 reference

title

Angiogenesis modulation in cancer research: novel clinical approaches (English)

1 reference

4 August 2017

1 reference

3

Gabriel N Hortobagyi

1 reference

4 August 2017

Massimo Cristofanilli

series ordinal

1

object named as

Massimo Cristofanilli

1 reference

4 August 2017

author name string

Chusilp Charnsangavej

series ordinal

2

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Nature Reviews Drug Discovery

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

415-426

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd819

4 August 2017

exact match

0 references

cites work

Mechanisms of angiogenesis and arteriogenesis

1 reference

Transplacental carcinogenesis by stilbestrol

31 March 2020

1 reference

Halting angiogenesis suppresses carcinoma cell invasion

31 March 2020

1 reference

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells

31 March 2020

1 reference

Angiogenesis in cancer and other diseases

31 March 2020

1 reference

Vascular-specific growth factors and blood vessel formation

31 March 2020

1 reference

31 March 2020

The Hallmarks of Cancer

1 reference

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

31 March 2020

1 reference

A mathematical model for the roles of pericytes and macrophages in the initiation of angiogenesis. I. The role of protease inhibitors in preventing angiogenesis

31 March 2020

1 reference

3-Amidinophenylalanine-based inhibitors of urokinase

31 March 2020

1 reference

Ribozyme approach to downregulate vascular endothelial growth factor (VEGF) 189 expression in non-small cell lung cancer (NSCLC).

31 March 2020

1 reference

Angiostatin generation by human tumor cell lines: involvement of plasminogen activators.

31 March 2020

1 reference

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

31 March 2020

1 reference

Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells

31 March 2020

1 reference

Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells.

31 March 2020

1 reference

Ras regulation of vascular endothelial growth factor and angiogenesis

31 March 2020

1 reference

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

31 March 2020

1 reference

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas

31 March 2020

1 reference

Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature

31 March 2020

1 reference

VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways

31 March 2020

1 reference

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

31 March 2020

1 reference

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

31 March 2020

1 reference

Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging

31 March 2020

1 reference

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor

31 March 2020

1 reference

BOLD MRI of human tumor oxygenation during carbogen breathing

31 March 2020

1 reference

Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density

31 March 2020

1 reference

Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging

31 March 2020

1 reference

Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model

31 March 2020

1 reference

In vivo monitoring of tumor angiogenesis with MR imaging.

31 March 2020

1 reference

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis.

31 March 2020

1 reference

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

31 March 2020

1 reference

Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.

31 March 2020

1 reference

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

31 March 2020

1 reference

Assessing tumor angiogenesis using macromolecular MR imaging contrast media.

31 March 2020

1 reference

Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents

31 March 2020

1 reference

Enhanced color flow imaging of breast cancer vasculature: continuous wave Doppler and three-dimensional display

31 March 2020

1 reference

Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival

31 March 2020

1 reference

Breast cancer vascularity: color Doppler sonography and histopathology study

31 March 2020

1 reference

Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels.

31 March 2020

1 reference

Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP-470, an angiogenic inhibitor

31 March 2020

1 reference

Role of radionuclide imaging in trials of antiangiogenic therapy

31 March 2020

1 reference

Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review

31 March 2020

1 reference

Bolus dynamics: theoretical and experimental aspects

31 March 2020

1 reference

Clinical implications of circulating angiogenic factors in cancer patients

31 March 2020

1 reference

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

31 March 2020

1 reference

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer

31 March 2020

1 reference

Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data

31 March 2020

1 reference

Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies

31 March 2020

1 reference

Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model

31 March 2020

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

31 March 2020

1 reference

Randomized discontinuation trials: Utility and efficiency

31 March 2020

1 reference

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

31 March 2020

1 reference

Clinical trial designs for cytostatic agents

31 March 2020

1 reference

Randomized discontinuation design: application to cytostatic antineoplastic agents

31 March 2020

1 reference

Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer

31 March 2020

1 reference

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

31 March 2020

1 reference

Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1

31 March 2020

1 reference

Non-Randomized Controls in Cancer Clinical Trials

31 March 2020

1 reference

Optimal two-stage designs for phase II clinical trials

31 March 2020

1 reference

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

31 March 2020

1 reference

How tumors become angiogenic

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD819

1 reference

4 August 2017

1 reference